Study Shows Rasilez, The First And Only Approved Direct Renin Inhibitor, Reduces A Marker Of Heart Failure Severity And Is Well-Tolerated

Interesting initial information with this new class of blood pressure medication...BD

Rasilez (aliskiren), the first new type of high blood pressure medicine in more than a decade, is generally well-tolerated and can potentially reduce the severity of heart failure1 based on new data showing significant reductions in BNP, a substance secreted by the heart and whose levels are viewed as an indicator of disease severity.

Study Shows Rasilez, The First And Only Approved Direct Renin Inhibitor, Reduces A Marker Of Heart Failure Severity And Is Well-Tolerated